Intracellular Notch (ICN) initiates DNA transcription in cooperation with CSL that acts as repressor in the absence of ICN. The ICN mediates recruitment of MAML protein, leading to the formation of minimal transcriptional complex, MAML/ICN/CSL/DNA. Crystal structure reveals that different conformations exist between the free (CSL/DNA) and bound (ICN/MAML/CSL/DNA) forms. The significance of this modulation of the CSL/DNA molecular complex can be better understood by experimental approaches that aim to elucidate the cause and timing of these events. There are four orthologues of human ICN (ICN1-4). We studied interactions between human full-length ICN1 and CSL/DNA without involvement of MAML, in vitro, and found that 1) the EMSA profile of CSL/DNA is altered in the presence of ICN1 as a consequence of an intrinsic change(s) in CSL/DNA, and not due to the formation of an ICN/CSL/DNA molecular complex; 2) ICN1 destabilizes CSL/DNA. These findings indicate that human ICN1 functions to modulate the CSL/DNA molecular complex for subsequent recruitment of MAML, and that modulated CSL/DNA cannot accommodate ICN1 in the absence of MAML. The latter in turn, implies that the formation of the MAML/ICN1/CSL/DNA is likely to be a collective event, wherein preassembly of MAML and ICN1 as a binary complex co-localizes at the CSL/DNA promoter site, or the MAML/ICN1/CSL complex is pre-assembled prior to binding to the promoter, rather than ICN1 arriving at CSL/DNA ahead of MAML and/or other associated transcription factors. The novel finding that ICN1 destabilizes the CSL/DNA complex opens new possibilities of transcriptional regulation by Notch.
Introduction
Notch is a transmembrane receptor protein that controls numerous developmental decisions through binding of ligands displayed on the surface of adjacent cells. Notch signaling pathway regulates cell fate decisions in neurogenesis [1], T cell development [2] and hypoxia [3] and has been implicated in multiple cross talks with major pathways that influence cell proliferation, differentiation, survival and migration [4] . Aberrations in Notch receptors have been linked to malignancies [5] [6] [7] [8] [9] , and lately, the components of Notch signal transduction have been targeted in anti-cancer drug development [10] [11] [12] .
Upon ligand binding, the Notch receptor is proteolytically cleaved at the membrane site, and intracellular Notch (ICN) migrates to the nucleus, where it interacts with various promoters to stimulate transcription in cooperation with transcription factor CSL (also known as RBP-J, CBF1, Su(H) and LAG-1), reviewed [13] [14] [15] . In the absence of ICN, CSL acts as a transcriptional repressor, bound at the promoter to "GTGGGAAA" CSL specific sequence. The ICN has not been found to bind directly to DNA but its RAM domain (RAM = RBP-J Associating Molecule) and Ankyrin domain (ANK) interact with CSL [16] . Transcriptional repression by CSL is reportedly achieved through recruitment of histone deacetylase complexes, SMRT/mSin3A/HDAC-1 or NCor/ nSin3A/HDAC-1 [17] , CIR/SAP30/HADC-2 [18] or SHARP/CtIP [19] to a gene promoter site and compacting of the chromatin. It is believed that ICN1 plays an important role in displacing the co-repressor complexes, allowing the chromatinized DNA to unfold and thus fa-The results of these experiments suggest that human ICN1 can induce a conformational change(s) in CSL/ DNA, and recruit additional DNA sequence(s) that maintain CSL binding to the core promoter during the interaction. Our data complement and expand the existing knowledge of ICN1 interaction with CSL/DNA; we demonstrate that use of the full-length human ICN1 (and not the RAMANK truncated form of murine ICN), is capable of conformational change(s) in CSL/DNA. In addition, we show that ICN1 alone is capable of inducing the change (likely, to accommodate MAML binding to CSL/DNA) but cannot form stable association with CSL/DNA without MAML (likely because the new conformation of CSL/DNA favors binding of ICN1/MAML but not ICN1). The results imply that in human species binding of MAML and ICN1 to CSL/DNA at Hes1 promoter is a simultaneous, mutually assisted event. Another interesting finding of this work is destabilization of the CSL/DNA complex by Notch, which potentially may play a role in negative regulation of transcription.
Materials and Methods

Antibodies and Transfection Reagents
Anti-Flag M2 antibody (F1804), anti-Flag M2 antibody HRP conjugate (A8592), anti-Flag M2 affinity gel (A2220), anti-HA monoclonal antibody, clone HA-7, HRP conjugate (H6533), anti-HA monoclonal antibody (H9658), anti-polyHistidine monoclonal antibody (H1029) were obtained from Sigma (Sigma Chemicals, St. Louis, MO, USA); anti-6xHis tag antibody HRP conjugate (ab1187) was obtained from Abcam (Abcam, Cambridge, UK), anti-ICN1 polyclonal serum (goat) was prepared in the lab. DMEM and RPMI media, Lipofectamine 2000 and Lipofectamine TM were purchased from Invitrogen (Invitrogen, Carisbad, CA, USA).
DNA Sequences
For EMSA probes, we used fragments of HES1 promoter (ENSEMBL genome ID: ENST00000232424, human chromosome 3: 195,853,833 to 195,853,892). The basic 59 bp probe imitated −101 to −42 fragment of the transcription start (−337 to −278 before the ATG translation initiation codon) of that sequence. The purified DNA duplexes were purchased from Eurofins MWG (Huntsville, AL, USA, oligo-us@eurofins.com).
of E. coli. Expression of the ICN1 and 6His-ICN1-6His recombinant proteins: 0.4 mM IPTG at OD600 = 0.8, 3 hours, 37˚C after induction; Expression of CSL, CSL6His Flag-CSL and Flag-CSL-6His recombinant proteins: 0.4 mM IPTG at OD600 = 0.8 followed by overnight growth at 16˚C: at such conditions ~80% of the recombinant CSL protein was soluble. The 6His-tagged proteins were purified using Ni-NTA Agarose (Invitrogen R901-01 or Qiagen 30230) according to manufacturers' instructions at native conditions. After purification, proteins were dialyzed in phosphate buffer (50 mM NaH 2 PO 4 pH 8.0, 500 mM NaCl) snap-frozen and stored at −80˚C or stored at −20˚C in if dialyzed in phosphate buffer in presence of 40% glycerol.
CSL and ICN1 Protein Expression in HEK293T Cells
HEK293T cells were transiently transfected in a 10 cm tissue culture dish with 2 -10 µg of a recombinant vector DNA, using Lipofectamin 2000 or Lipofectamin TM reagents. Cells were harvested for protein extract preparation in 24 -72 hours: washed with an ice-cold PBS, then scraped from the plate and transferred to a 15 ml Falcon polypropylene tube. After pelleting by centrifugation, the cells were lysed by osmotic shock on ice for 10 min. in 1 ml/10 7 cells of the Hypotonic lysis buffer (10 mM TrisHCl, pH 7.4, 10 mM NaCl, 2 mM EDTA, 0.5% Triton X-100) in the presence of 1 mM PMSF and a 1:50 dilution of protease inhibitor cocktail (Sigma P8340). After lysis, the NaCl concentration was adjusted to 150 mM and the cell extract was cleared of debris by centrifugation at 4˚C for 15 minutes at maximum speed on a microcentrifuge, the extracts were taken for EMSA analysis immediately or snap-frozen in aliquots and stored at −80˚C prior to single use. Protein expression in the extracts was confirmed by Western blotting.
ChIP/PCR Assay
Chromatin immunoprecipitation was adapted from the published protocol [32] with adjustment for antibodyagarose conjugates (precipitation with protein A was not necessary). Small fractions of cell culture were scraped prior to cross-linking with formaldehyde for analysis of protein expression by SDS-PAGE/Western blotting. PCR Primers: CCCTGGCTCCAAAAGAAATAGAC and GAAGTTTCACACGAGCCGTTCG. After running PCR products in 1.5% TAE agarose gel, quantification of the bands was done with GeneTools Version 4.01 software (Syngene (A Division of Synoptics Ltd), Beacon House, Cambridge, CB41TF, England).
EMSA
The EMSA Accessory Kit (Novagen 71282-3) was used for sample preparation according to manufacturer's instructions. (4× EMSA binding buffer = 400 mM KCl, 8  mM HEPES, 2 mM DTT, 0.8 mM EDTA, 80% glycerol,  pH 8.0; 1× EMSA binding buffer was supplemented with  sonicated salmon sperm DNA (125 -200 ng) and Poly (dI-dC) (dI-dC) (0.01U)). EMSA sample (20 ml) contained, unless specified otherwise, 300 nM of DNA probe (10,000 -100,000 cpm of 32 P activity) 2 -10 mg of total protein extract or 100 -400 nM (100 -300 ng)/reaction of purified CSL or ICN1. The DNA/CSL mix was pre-incubated on ice for 10 minutes prior to loading in gel. After addition of ICN1, the sample was loaded in gel and ran immediately or pre-incubated on ice for up to 30 minutes, and then ran, at 7.5 V/cm for 2 -8 hours (depending on the required resolution) at room temperature. The 15 × 20 cm 1 mm -1.5 mm thick 4% -6% TBE acrylamide:bis (29:1) gel was pre-run for 30 -40 min prior to loading the samples. After the run was finished, the gel was taken off the glass plates, wrapped in plastic film and exposed to autoradiography film or to a phosphorimaging screen.
EMSA/Western Blotting
The DNA and proteins from EMSA gel were transferred on to a PVDF membrane (Immobilon-P Cat. No: IPVH 00010 Millipore, Billerica, MA, USA), using the optimized protocol for semi-dry transfer: Three transfer buffers, containing 10% methanol were: anode buffer I (0.3 M Tris pH 10.4), anode buffer II (25 mM Tris pH 10.4), and cathode buffer (25 mM Tris and 40 mM e-aminocaproic acid, pH 9.4). The transfer membrane, sandwiched between transparent plastic sheets, was then exposed to a film (2 hours at −80˚C with enhancer screen), or a phosphorimaging screen, with reference points marked at the membrane. After radioactivity exposure, Western blotting analysis was done in a single step, using an HRP-conjugated (anti-Flag, anti-HA or anti-6His) antibody.
Phosphorimaging Analysis
Special care was taken to ensure equal distribution of CSL and 32 P-labeled DNA probe between the "No ICN1" and "+ICN1" samples prior to loading. After each run, the wet EMSA gel was placed between plastic sheets and exposed to 32 P sensitized phosphorimaging screen for 2 -6 hours. Image reading and quantification was done with Image Quant software (Molecular Dynamics, Foster City, CA). [33] . The 59 bp wild type (WT) probe, "59 bp CPS", referred to as CPS for CSL Paired Sites [34] had the two original sites: one site-GTGGGAAA-was closer to 5'-end of the fragment and designated "5'CS" (CS = CSL Site)," and the other-TTTCACAC (antiparallel)-was closer to 3'-end of the fragment and designated "3'CS". Derived from the "59 bp CPS" probe were two shorter WT probes: "18 bp 5'CS" contained only one (5'CS) CSL site [29] and "21 bp No CS" contained no CSL sites. There were also three full-length mutant probes: "59 bp 5'CS" and "59 bp 3'CS" had only one alternative CSL site-active and another-inactivated by mutations, and "59 bp No CS", where both sites were inactivated (Figure 1(a) ).
DNase Footprinting Analysis
Using the WT and the mutant 59 bp probes, we confirmed CSL site-specificity of DNA shifts in EMSA with HEK293T cell extract overexpressing untagged fulllength recombinant human CSL (Figure 1(b) , right panel), and titrated the amount per reaction of bacterially expressed purified CSL-6His to comparable results (Figure 1(b) , left panel). Consistent with the number of active CSL sites per probe, "59 bp CPS" produced two bands in the shift, corresponding to one and two CSL molecules bound to a single DNA probe (Figure 1(b) lane 1); "59 bp 5'CS" and "59 bp 3'CS" each produced single band (Figure 1(b) lanes 2 and 4) ; and "59 bp No CS"-produced no EMSA shifts at all (Figure 1(b) lane  3) . Having confirmed experimentally that the mutations eliminated CSL specificities of the CSL sites, we no longer used "59 bp No CS" probe as negative control but used the "21 bp No CS", instead.
After confirming the binding of the recombinant CSL to DNA in EMSA, we tested "ICN1+DNA" mixtures. The ICN1 produced no specific EMSA shifts with any of the CS-containing probes (not shown) but when added to pre-incubated CSL/DNA, it created visible impacts: 1) the primary CSL/DNA shift was retarded (Figure 1(c) lane 2) and 2) the shift was either weakened (as with "59 To exclude artifact, potentially brought by 6Histag of recombinant ICN1, we replaced the purified 6His-ICN1-6His in the reaction by soluble E. coli extract, overexpressing untagged ICN1 (ICN1/E.coli): the "ICN1/ E.coli" extract produced the same effects as the purified 6His-ICN1-6His protein (Figure 1(d) lane 2) whereas E.coli extract without ICN1 expression (E. coli) had no impact (Figure 1(d) lane 3) . Secondly, we used sequentially decreasing concentrations of ICN1 with constant concentration of CSL, in EMSA reactions. The expected outcome was coexistence in EMSA of two bands (one for CSL/DNA and one for ICN1/CSL/DNA) when CSL was in excess to ICN1 and the amount of ICN1 was sufficient to produce a visible secondary shift. Instead, only the secondary shift was present and no primary shifts, with four sequential dilutions of ICN1 (Figure 2 (b) lanes 2 -5); The last sample in the range, where ICN1 concentration was the lowest, contained only the primary shift but no secondary shifts (Figure 2 lane 6), presumably because the dilution of ICN1 reached the point where supershifting effect could no longer be produced at given conditions. Such result was more consistent with a conformational change in the CSL/DNA molecular complex than with ICN1 joining the complex.
Finally, we used EMSA/Western blotting technique to Based on these findings we concluded that the secondary EMSA shift of "+ICN1" sample was not ICN1/ CSL/DNA molecular complex but an alternative conformation of CSL/DNA molecular complex, induced by ICN1.
Weakening of EMSA Shifts in "+ICN1" Samples is Due to CSL/DNA Dissociation
The second effect, weakening of EMSA shift in "+ICN1" samples, indicated dissociation of DNA from CSL/DNA molecular complex. We measured the effect quantitatively and confirmed that when the amount of DNA in the shift was decreasing, the amount of free (unbound) DNA was complementary increasing in the same sample (Figure 3(a) The total DNA loads of "-ICN1" and "+ICN1" samples varied negligibly (raw measurements prior to converting to "% of total" are provided in Table  S1 ), excluding loss of DNA by degradation. The CSL/ DNA was dissociated about 50% when 59 bp CPS probe was used ( 
DNase Footprinting Analysis Supports Conformational Change in DNA/CSL in Presence of ICN1
Since the length of the DNA probe played a role in the extent of DNA dissociation from CSL/DNA in presence of ICN1 whereas CSL binding sites did not seem to have influence, we were seeking an additional evidence of involvement of sequence(s) other than CSL binding sites of the "59 bp CPS" during the DNA/CSL-ICN1 interaction. Our method of choice was DNase footprinting analysis. We kept the CSL concentration at minimum (to enhance the sensitivity to ICN1) and added ICN1, trying to identify the changes in the degenerate DNA ladder. In the previous section, we showed that full-length human ICN1 caused partial dissociation of CSL from the Hes1 promoter in vitro in the absence of stabilizing transcription factors. To find out if similar effect of ICN1 takes place in vivo, we used chromatin immunoprecipitation (ChIP) [32] from the cells, transiently transfected with CSL and ICN1 genes. Modeling the interaction between CSL/DNA and ICN1 in vivo without interference of other Notch-related factors presented a challenge. We minimized such interference by using the non Notchexpressing transfected host cell line, HEK293T, which is not expected to express Notch-specific factors in stoichiometric amounts to the overexpressed recombinant ICN1 and CSL. Robust overexpression of ICN1 and CSL genes in HEK293T would dwarf any background activity of the endogenous CSL, present in HEK293T [35] , but to clear the background even further we used Flag-tagged human CSL expression (Flag-CSL) for anti-Flag rather than anti-CSL ChIP assay. Anti-Flag ChIP/PCR from Flag-CSL-transfected cells confirmed that the recombinant Flag-CSL protein is bound to Hes1 promoter (Figure 4(a) lane 7) . In contrary, anti-ICN1 ChIP/PCR from the cells co-transfected with CSL and ICN1 genes together was negative, disregarding the type of the antibody, used (Figure 4 (a) lanes 4-6 as shown). The result suggested that ICN1 was either unbound to CSL/DNA or the immunoprecipitation of ICN1/CSL/DNA complexes by ICN1 epitops was inefficient. We targeted Flag-epitope after "Flag-CSL + Flag-ICN1" co-transfection-and such ChIP/PCR was positive but HES1 promoter was under-represented in "CSL + ICN1"-transfected cells compared to "CSL only"-transfected cells (Figure 4(b) upper panel lanes 1 and 2) . Serial testing of anti-Flag ChIP/PCR after co-transfections of cells with Flag-CSL plus either ICN1-HA, 6His-ICN1 or untagged ICN1 suggested that the target epitope that helped bring down the HES1 promoter belonged to Flag-CSL and not to ICN1 (Figure 4(b) lanes  1 and 2, all panels) . Anti-ICN1 ChIP was negative not only for "CSL+ICN1" transfected cells (as described) but also for "ICN1 only" transfections (Figure 4(b) lane 3, all panels). Prior to each ChIP experiment, the expression of CSL and ICN1 proteins was confirmed by Western blotting (Figure 4(c) , for Flag-CSL and ICN1-HA pro- teins), excluding the possibility that under-representation of HES1 promoter was caused by the lack of Flag-CSL.
Interesting to note that Flag-CSL and ICN1-HA could be co-immunoprecipitated together from the extracts of co-transfected HEK293T, as detected by Western blotting (Figure 4(d) ), indicating that Flag-tag epitope of the Flag-CSL was accessible in the Flag-CSL/ICN1-HA protein pair complex, at least when unbound to DNA. In summary to the in vivo results, we concluded that in the transfected HEK293T cells 1) ICN1 was not associated with HES1 promoter, 2) ICN1 was not associated with CSL/DNA complex at HES1 promoter, and 3) ICN1 caused partial dissociation of CSL from HES1 promoter. To further substantiate these conclusions, we analyzed the transfected HEK293T extracts in EMSA. 10 and 13, 14) . N/S * -"Non-specific" DNAbinding activity of 293T extract, located very closely to 2XCSL/DNA band. lanes 3 and 4). When the extract of the cells, co-transfected with CSL+ICN1 genes (CSL+ICN1)/293T (Figure 5(a) lane 2) or the mixture of ICN1/293T + CSL/293T extracts (Figure 5 (a) lanes 6 and 7 for tagged and untagged modifications of ICN1) were used in EMSA, CSL/DNA band was supershifted much higher in the gel: the effect resembling that of bacterially expressed/purified ICN1 except the larger magnitude of retardation. RAM-and Ankyrin-deletions of ICN1 (ICN1DRAM/ 293T and ICN1DANK/293T) abolished the effect of WT ICN1/293T (Figure 5(a) lanes 8 and 9) , pointing to a direct involvement of ICN1 in the supershifting. Shorter or longer exposure of pre-formed CSL/ 59 bp CPS to WT ICN1/293T had no difference: the full effect took place at "zero time" to the same extent as after 40 minutes of pre-incubation (Figure 5(b)) .
We compared the effects of the "59 bp CPS", "21 bp No CS" and "18 bp 5'CS" probes-and the results were similar to bacterially expressed/purified CSL and ICN1 (except the depth of retardation of the CSL/DNA shift): there was a primary CSL/DNA shift formed with the "59 bp CPS" and "18 bp 5'CS" probes, and not with the "21 bp No CS" probe ( Figure 5(c) lanes 1-3) ; two characteristic bands were seen in the shift with the "59 bp CPS" ( As inferred from ChIP/PCR data (in Section 2.5), ICN1/293T extract induced obvious dissociation of CSL/ DNA molecular complex in case of the 18 bp 5'CS probe, but the super-retardation of the 59 bp CPS without an apparent reduction of DNA material in the shift had to be explained.
We compared the 18 bp 5'CS probe with other CS probes in EMSA with ICN1/293T (Figure 5 (c) right panel): Unlike the 18 bp 5'CS probe, the 59 bp 5'CS and 59 bp 3'CS probes did not show obvious signs of dissociation (Figure 5(c) lanes 10 and 14 vs lane 12) , implying the involvement of extra sequence of 59 bp probe in maintaining stability during the interaction with ICN1. Surprisingly, both 59 bp CS probes performed identically to the 59 bp CPS probe by producing the double-banded pattern of the super-retarded shift (Figure 5(c) lanes 8,  10 and 14 ). In EMSA with purified CSL and ICN1 (as described in Section 2.2) , the double-banded pattern of the CSL/DNA shift was due to two CSL binding sites present in one probe (the exclusive feature of the CPS probe), but that did not seem to be the case for the double-banded pattern of the super-retarded shift in EMSA with HEK293T extracts. Rather, they represented either ICN1/CSL/DNA + X/ICN1/CSL/DNA or X/CSL/DNA + X/DNA molecular complexes, where "X"-unidentified factor(s) from HEK293T extract. We further elucidated the possibilities using EMSA/Western blotting and DNA quantification. Figure 6(b) ).
EMSA/Western
DNA Quantification Provides Evidence of Partial CSL Dissociation from CSL/X/DNA in Presence of ICN1/293T
Quantitative analysis revealed higher contents of 32 P-labeled DNA probe in the super-retarded shift of the "+ICN1/293T" sample than in the primary CSL/DNA shift of "No ICN1" sample (40% of the total in lane 2 compared 34% in Figure 6(c) ). Since the amounts of CSL protein were strictly equalized between the samples in lanes 1 and 2, at least some of the DNA in the super-retarded shift (6% or more of the total in Figure 6 (c)) had to be bound in the protein complexes without CSL: Subsequently, the CSL-heterogeneity of the shift, detected by Western blotting, was supported by quantification of DNA in EMSA bands. Presuming that the lower band of the super-retarded shift is X/DNA (no CSL, no ICN1) molecular complex, and the upper band-CSL/X/DNA molecular complex, the amount of CSL in the DNA-bound molecular complex of "+ICN1/293T" sample (CSL/X/DNA) can be compared with the amount of CSL in the "No ICN1" sample (CSL/DNA) by quanti- fication the equamolar amounts of the DNA in the correspondent EMSA bands. Interestingly, with such presumption only ~half of the CSL is still bound to the DNA sa DNA in lane 1, Figure 6(c) ), meaning that CSL dissociated in presence of ICN1: consistent with ChIP/PCR data and remarkably similar to the EMSA results obtained with purified ICN1 and CSL.
Discussion
The goal of this study was to evaluate the impact of fulllength human ICN1 protein on CSL/DNA molecular complex. The experimental re function alone t complex, at HES suggest that full length human ICN1 does not form a stable association with CSL/DNA but induces a conformational change in CSL/DNA; the ICN1-induced CSL-DNA conformation is unstable and prone to dissociation; the bond between the CSL and DNA in the new conformation may involve HES1 promoter sites other than the consensus CSL-binding sites. Transient dissociation of the CSL/DNA complex may sponsor the recruitment of additional factors and DNA sequences.
We acknowledge that several research groups have reported detectable ICN/CSL/DNA shifts in EMSA [20, 29] , although the lack of binding of ICN1 to DNA/CSL was also reported: [22] . A number of reasons may account for these differences, amongst them Human ICN1 and non-human ICN1 may possess different binding affinities/stoichiometry for the CSL/ DNA;  In the most studies, the ICN1/CSL/DNA molecular complex was reportedly assembled w ICN1 (ANK, RAM or RAMANK domains, etc.): The use of a non-truncated, full-length human ICN1 could alter p CSL/DNA;  The in vitro setup and DNA probes are not identical and often differ between laboratories and this can lead to discrepancies in data outcomes;  A conformational change in CSL/DNA could decrease electrophoretic falsely identified as the ICN1/CSL/DNA molecular complex in EMSA: the presence of ICN1 in the shift must be verified; An excellent illustration of the interspecies differences is provided in the recent publication by Kovall and coworkers [36] wherein they report a 50-fold difference in affinity of the RAM domain to CSL between the worm and mouse species. In RAM domain to induce modulation of CSL/DNA is only 50% compared to the extent of modulation found in the ternary complex (MAML/ICN/CSL + DNA) with RAMANK-can serve as an illustration of change that is initially influenced by the size of the truncated ICN1. Of course, in the latter case there is also unknown contribu-tion of MAML protein.
The binding of MAML to CSL/DNA is dependent upon the participation of ICN1, because it requires opening the loop in N-terminal domain of CSL that remains closed in the free CSL/DNA form, as presumed from crystallization studies [30, 37] . The instability of C co-repressor proteins that exist at much hi SL/DNA, detected in our experiments, implies that CSL conformation in the MAML/ICN1/CSL/DNA complex (as seen in crystal structure) is different from the conformation induced by ICN1 in the absence MAML, because the ternary complex is not characterized by low affinity to DNA. Instead, CSL prints in DNA footprinting are enhanced with MAML [20] . Thus, it is likely that MAML, in turn, re-configures the CSL/DNA complex that is modulated by ICN1, and stabilizes the bond of CSL with DNA. Our model presumes that highest level of cooperation between ICN1 and MAML is required to produce maximal affinity for binding to CSL/DNA. The interaction of ICN1 with DNA/CSL lasts seconds, taking into account that the mixed (ICN1 + DNA/CSL) samples were applied immediately to the EMSA [the interacting molecules are "fixed" together by "caging effect" after entering the gel [38] and the time of entry into the gel lasted less than 1 minute. ICN1 opens CSL conformation and compromises the CSL bond with the promoter DNA. The allosteric modulation of CSL/DNA that is induced in the presence of ICN1 may prove to be of higher significance than physical association of ICN1 with the CSL/ DNA molecular complex. Jones and co-workers have discussed that "transactivation" by Notch is achieved through recruitment of available non-DNA-binding co activators such as MAML, SKIP, Deltex, and not by functionality of ICNs own domains [20] . There is a growing family of factors, known to interact with Notch, whose function is not completely understood. MAML proteins interact with partners other than Notch and CSL, and the Notch pathway that competes for MAML1, titrates this protein molecule from interacting with the other transcription factors [39] . SKIP, binding to CSL and ICN, may well prove to be another "stabilizer" of ICN1-CSL/DNA, alternative to MAML, but crystal structure of SKIP/ICN1/ CSL/DNA is yet to be determined. Deltex does not bind to CSL [40] , but may act with ICN to modulate other enhancer-binding proteins. Many genes that contain CSLbinding sites in their promoters are not always responsive to ICN, despite the presence of CSL in the nuclei of the cells [41, 42] ; The ability of Notch to modify CSL/DNA, and potentially, "Another Effector/DNA", opens an intriguing possibility that activation of Notch-regulated promoters is achieved through recruitment of multiple different, promoter-specific co-activators (MAML, SKIP, Deltex, etc.), which may take advantage of the universal function of ICN1 as "modulator" of enhancer-binding protein/DNA complexes (including the CSL/DNA). In some cases, "opening" of an enhancer-binding protein (such as CSL) may be the only necessary and sufficient role of ICN1; In the case of HES1 transcription, ICN1 actively modulates CSL into a configuration that accepts the transcription co-activator MAML, plus ICN1: if MAML is available and appropriately positioned at the time of ICN1-CSL/DNA interaction, the "open" conformation is re-adjusted and a stable MAML/ICN1/CSL/ DNA transcription complex is formed; if MAML is unavailable-CSL may dissociate or revert to the "free DNAbound" conformation, and thereby inhibit transcription. Recent studies reveal that the consensus CSL binding sequences are present in hundreds if not thousands promoters of different genes, and CSL occupancy of those promoters is quite high [43, 44] ; Thus, the differential expression of promoter-specific CSL/DNA-stabilizing factors may even form the basis of precise response(s) to Notch signaling.
The Notch-induced instability/modulation of CSL/ DNA promoter complexes as demonstrated in this study contributes to our understanding of how Notch, when expressed in small amounts within the nucleus, can displace CSL-bound gher concentrations [2] . The current theory is that SKIP protein assists Notch in the displacement of co-repressors from CSL [45] . Another possibility is that allosteric modulation of CSL/DNA can render a conformation not favorable to binding of co-repressor complexes, thus causing their dissociation. Or even that the CSL may dissociate from the promoter itself upon ICN1 impact, vacating the place to pre-assembled MAML/ICN1/CSL molecular complexes, whose existence is in discussion in the alternative model of Notch activation [36, 46, 47] , different from the model where CSL is constantly statically bound to DNA.
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N-terminal ICN1 sequence (with 6xHis epitope) added when cloned in pET28a:
3/1 33/11 atg ggc agc agc cat cat cat cat cat cac agc agc ggc ctg gtg ccg cgc ggc agc cat Met gly ser ser his his his his his his ser ser gly leu val pro arg gly ser his 63/21 93/31 BamHI atg gct agc atg act ggt gga cag caa atg ggt cgc gga tcc met ala ser met thr gly gly gln gln met gly arg gly ser 
